Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page
- Check7 days agoChange DetectedAn NIH banner announces a website transition and says that “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov error page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer's revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message and effectively hiding the study record and its related navigation.SummaryDifference20%

- Check63 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata. No changes to the study details or results are reflected by this update.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page in the system.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.